Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs IPCA LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH IPCA LABS PROCTER & GAMBLE HEALTH/
IPCA LABS
 
P/E (TTM) x 35.6 48.0 74.1% View Chart
P/BV x 10.9 5.0 217.3% View Chart
Dividend Yield % 2.0 0.3 562.2%  

Financials

 PROCTER & GAMBLE HEALTH   IPCA LABS
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Jun-23
IPCA LABS
Mar-23
PROCTER & GAMBLE HEALTH/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs5,3661,062 505.3%   
Low Rs3,883768 505.6%   
Sales per share (Unadj.) Rs740.7243.0 304.9%  
Earnings per share (Unadj.) Rs138.219.4 712.9%  
Cash flow per share (Unadj.) Rs155.229.7 522.4%  
Dividends per share (Unadj.) Rs95.004.00 2,375.0%  
Avg Dividend yield %2.10.4 469.9%  
Book value per share (Unadj.) Rs447.6230.3 194.4%  
Shares outstanding (eoy) m16.60253.70 6.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x6.23.8 165.8%   
Avg P/E ratio x33.547.2 70.9%  
P/CF ratio (eoy) x29.830.8 96.7%  
Price / Book Value ratio x10.34.0 260.0%  
Dividend payout %68.720.6 333.1%   
Avg Mkt Cap Rs m76,761232,120 33.1%   
No. of employees `000NANA-   
Total wages/salary Rs m2,06212,876 16.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m12,29661,642 19.9%  
Other income Rs m1841,518 12.1%   
Total revenues Rs m12,48063,160 19.8%   
Gross profit Rs m3,2479,033 35.9%  
Depreciation Rs m2812,616 10.7%   
Interest Rs m8482 1.6%   
Profit before tax Rs m3,1427,453 42.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8472,534 33.4%   
Profit after tax Rs m2,2954,919 46.6%  
Gross profit margin %26.414.7 180.2%  
Effective tax rate %27.034.0 79.3%   
Net profit margin %18.78.0 233.8%  
BALANCE SHEET DATA
Current assets Rs m11,71351,893 22.6%   
Current liabilities Rs m6,79118,058 37.6%   
Net working cap to sales %40.054.9 72.9%  
Current ratio x1.72.9 60.0%  
Inventory Days Days26351 513.0%  
Debtors Days Days3436 5,865.0%  
Net fixed assets Rs m10,61734,336 30.9%   
Share capital Rs m166254 65.4%   
"Free" reserves Rs m7,26558,167 12.5%   
Net worth Rs m7,43158,420 12.7%   
Long term debt Rs m06,518 0.0%   
Total assets Rs m22,33086,229 25.9%  
Interest coverage x409.116.5 2,484.3%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.60.7 77.0%   
Return on assets %10.36.3 164.6%  
Return on equity %30.98.4 366.7%  
Return on capital %42.412.2 346.9%  
Exports to sales %042.9 0.0%   
Imports to sales %13.113.3 98.4%   
Exports (fob) Rs mNA26,434 0.0%   
Imports (cif) Rs m1,6058,178 19.6%   
Fx inflow Rs m1,46526,434 5.5%   
Fx outflow Rs m1,6058,178 19.6%   
Net fx Rs m-14018,257 -0.8%   
CASH FLOW
From Operations Rs m2,3608,058 29.3%  
From Investments Rs m-215-7,250 3.0%  
From Financial Activity Rs m-9855,072 -19.4%  
Net Cashflow Rs m1,1605,881 19.7%  

Share Holding

Indian Promoters % 0.0 46.3 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 20.3 44.8 45.2%  
FIIs % 7.6 10.3 74.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 53.7 89.7%  
Shareholders   56,730 82,809 68.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Procter & Gamble Health vs IPCA Labs

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Procter & Gamble Health vs IPCA Labs Share Price Performance

Period Procter & Gamble Health IPCA Labs S&P BSE HEALTHCARE
1-Day -0.64% -1.35% -0.98%
1-Month -3.44% -6.26% -5.03%
1-Year -1.20% 47.27% 57.45%
3-Year CAGR -8.96% 7.72% 18.14%
5-Year CAGR 7.96% 20.11% 18.88%

* Compound Annual Growth Rate

Here are more details on the Procter & Gamble Health share price and the IPCA Labs share price.

Moving on to shareholding structures...

The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of IPCA Labs the stake stands at 46.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of IPCA Labs.

Finally, a word on dividends...

In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.

IPCA Labs paid Rs 4.0, and its dividend payout ratio stood at 20.6%.

You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of IPCA Labs.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3% Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3%(10:30 am)

Asian shares slipped before a Bank of Japan policy decision where authorities are likely to bring an end to the world's last negative rates regime.